483. Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with Hemodialysis

BACKGROUND: Nirmatrelvir/ritonavir (Paxlovid) is one of the few therapeutic options for COVID-19. It is not recommended to use in patients with end-stage renal disease (ESDR), and large-scale clinical trials are needed to support its application in this population. We investigated the pharmacokineti...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Ying, Huajian, Sun, Feng, Fan, Yaxin, Li, Yi, Liu, Xiaofen, Chen, Mengting, Guo, Beining, Xue, Jun, Zhang, Jiming, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677209/
http://dx.doi.org/10.1093/ofid/ofad500.553

Ejemplares similares

Ejemplares similares